# DRUGS MADE IN AMER ACQ II CO (DMIIU)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DMIIU/

- Reporting holders: 11
- Reported value: $37.5M
- Shares held by institutions: 3,695,039 of 63,700,000 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [LMR Partners LLP](https://holderbook.com/funds/1578621-lmr-partners-llp/) | $20.3M | 2,000,000 | 0.1% | 4 |
| [Westchester Capital Management, LLC](https://holderbook.com/funds/1512805-westchester-capital-management-llc/) | $5.1M | 502,914 | 0.3% | 4 |
| [Verition Fund Management LLC](https://holderbook.com/funds/1454027-verition-fund-management-llc/) | $5.1M | 500,000 | 0.0% | 4 |
| [BlueCrest Capital Management Ltd](https://holderbook.com/funds/1610880-bluecrest-capital-management-ltd/) | $2.5M | 250,000 | 0.1% | 4 |
| [Walleye Capital LLC](https://holderbook.com/funds/1758720-walleye-capital-llc/) | $1.0M | 100,000 | 0.0% | 4 |
| [L1 Global Manager Pty Ltd](https://holderbook.com/funds/1878742-l1-global-manager-pty-ltd/) | $1.0M | 100,000 | 0.7% | 3 |
| [READYSTATE ASSET MANAGEMENT LP](https://holderbook.com/funds/1900923-readystate-asset-management-lp/) | $1.0M | 100,000 | 0.0% | 4 |
| [HRT FINANCIAL LP](https://holderbook.com/funds/1475597-hrt-financial-lp/) | $1.0M | 99,725 | 0.0% | 4 |
| [Rangeley Capital, LLC](https://holderbook.com/funds/1517796-rangeley-capital-llc/) | $330.7K | 32,551 | 0.3% | 3 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $82.1K | 8,084 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $17.9K | 1,765 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 11 | $37.5M |
| Q1 2026 | 14 | $43.5M |
| Q4 2025 | 30 | $116.0M |
| Q3 2025 | 75 | $458.1M |